ArticleFrontiers in microbiology2026
Whole-genome analysis of mumps virus genotype F in Shandong, China (2006-2018).
Article in Frontiers in microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Despite the introduction of mumps-containing vaccines into the routine immunization program in 2008, mumps incidence in Shandong Province, China, declined but remained substantially higher than that of measles and rubella, and above WHO elimination thresholds, raising the possibility of whether genetic evolution of circulating strains has contributed to this phenomenon. To address, we compared mumps viruses isolated pre-vaccine (2006-2007) and a decade after rollout (2018). Methods: We analyzed mumps case data reported in Shandong from 2005 to 2024. We also performed whole-genome sequencing on 16 mumps virus strains isolated during the same period. Phylogenetic analyses were conducted to characterize viral genetic features and identify mutations. Results: From 2005 to 2024, 167,590 mumps cases were reported, peaking in 2012 (25.33 per 100,000 population). SH-gene typing consistently identified all 16 strains as genotype F, a result corroborated by whole-genome phylogeny; however, the SH gene alone proved insufficient for phylogenetic resolution among closely related strains, consistent with the value of whole-genome sequencing for epidemiological surveillance. The 16 full-length genomes shared 98.34-100% nucleotide identity. Phylogenetic analysis revealed intermingling of 2006-2007 and 2018 isolates rather than time-specific clustering, with low inter-group p-distances. Importantly, between the two temporal groups, no significant differences were detected in their respective identities to the vaccine strain S79 at the whole-genome level (nucleotide or amino acid). Two positively selected sites were identified across the seven structural proteins (posterior probability > 0.95). Eight mutations in HN and F that alter hydrophilicity, hydrophobicity, or charge were found, but structural modeling predicted no appreciable conformational changes. Conclusion: We provides a whole-genome-based, two-time point comparison of genotype F mumps viruses in Shandong across a ~ 12-year interval spanning vaccine introduction (2006-2007 vs. 2018). Overall, the Shandong 2018 isolates remained as similar to the 2006-2007 isolates as F strains are nationwide, and both groups were comparably close to vaccine strain S79, indicating no detectable genetic divergence or drift over the ~12-year period. As the SH gene alone lacked sufficient diversity to resolve closely related isolates, whole-genome sequencing provided more accurate genetic characterization in this study.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.